TickerFactsScreenerDevelopers

Ovid Therapeutics Inc. (OVID) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2014: $4.74M2015: $68.07M2016: $49.29M2017: $83.44M2018: $38.81M2019: $70.02M2020: $43.63M2021: $179.75M2022: $132.27M2023: $87.80M2024: $68.23M2025: $130.66M$130.66M
2014Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$130.66M+91.5%
2024$68.23M-22.3%
2023$87.80M-33.6%
2022$132.27M-26.4%
2021$179.75M+312.0%
2020$43.63M-37.7%
2019$70.02M+80.4%
2018$38.81M-53.5%
2017$83.44M+69.3%
2016$49.29M-27.6%
2015$68.07M+1336.6%
2014$4.74M—